Goertsen et al., 2022 - Google Patents
AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmosetGoertsen et al., 2022
View HTML- Document ID
- 17370509915566420693
- Author
- Goertsen D
- Flytzanis N
- Goeden N
- Chuapoco M
- Cummins A
- Chen Y
- Fan Y
- Zhang Q
- Sharma J
- Duan Y
- Wang L
- Feng G
- Chen Y
- Ip N
- Pickel J
- Gradinaru V
- Publication year
- Publication venue
- Nature neuroscience
External Links
Snippet
Genetic intervention is increasingly being explored as a therapeutic option for debilitating disorders of the central nervous system. The safety and efficacy of gene therapies rely upon expressing a transgene in affected cells while minimizing off-target expression. Here we …
- 230000014509 gene expression 0 title abstract description 104
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses
- C12N2750/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses ssDNA Viruses
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Goertsen et al. | AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset | |
| US12091659B2 (en) | High efficiency library-identified AAV vectors | |
| Chan et al. | Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems | |
| US10689420B2 (en) | AAV's and uses thereof | |
| Liu et al. | Crossing the blood-brain barrier with AAV vectors | |
| Cearley et al. | Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain | |
| Zincarelli et al. | Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection | |
| Powell et al. | AAV capsid-promoter interactions determine CNS cell-selective gene expression in vivo | |
| Klein et al. | AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method | |
| Lukashchuk et al. | AAV9-mediated central nervous system–targeted gene delivery via cisterna magna route in mice | |
| JP2022068181A (en) | Capsid-modified, raav3 vector compositions and methods of use in gene therapy of human liver cancer | |
| Benskey et al. | Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants | |
| Dirren et al. | Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type–specific transgene expression in the spinal cord | |
| Ayers et al. | Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice | |
| AU2018227440A1 (en) | Adeno-associated virus (AAV) clade f vector and uses therefor | |
| El Andari et al. | Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders | |
| Öztürk et al. | scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution | |
| Bell et al. | Effects of self-complementarity, codon optimization, transgene, and dose on liver transduction with AAV8 | |
| Flytzanis et al. | Broad gene expression throughout the mouse and marmoset brain after intravenous delivery of engineered AAV capsids | |
| CN116209768A (en) | Methods for engineering new hybrid AAV capsids by hypervariable region exchange | |
| Goertsen et al. | Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid | |
| Duncan et al. | Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA mice | |
| WO2021030225A2 (en) | Aav capsid variants for targeting human glioblastoma cells | |
| Finneran et al. | Toward development of neuron specific transduction after systemic delivery of viral vectors | |
| Gleichman et al. | A toolbox of astrocyte-specific, serotype-independent adeno-associated viral vectors using microRNA targeting sequences |